加拿大行政数据中慢性鼻窦炎的经验证病例定义
研究以100例基于指南诊断的慢性鼻窦炎(CRS)患者和100例对照者为样本,链接至2010年3月31日至2015年3月31日的加拿大医生索赔数据库,评估7种基于ICD-9的编码算法。结果显示,2年内≥2次CRS的ICD-9编码(471.x或473.x)索赔的病例定义具有平衡的效度,灵敏度77%、特异度79%。应用该定义产生51,000例CRS队列,其特征与已发表的人口学及合并哮喘、过敏性鼻炎和抑郁的比例一致。
要点
- 2年内≥2次CRS的ICD-9编码(471.x或473.x)索赔的病例定义灵敏度77%、特异度79%。
- 该定义应用于索赔数据库产生51,000例CRS队列,特征与已发表数据一致。
- 未来需从不同卫生系统视角并利用多提供者更大样本的回顾性病历审查来验证该行政病例定义。
核心结论
- 本研究验证了多种编码算法;基于结果,2年内≥2次CRS的医生索赔(ICD-9编码471.x或473.x)的病例定义提供了最佳效度水平。
研究设计与样本
- 随机抽取100例基于指南诊断的CRS患者和100例对照患者,链接至2010年3月31日至2015年3月31日的加拿大医生索赔数据库。
- 评估7种不同的基于ICD-9的编码算法的效度。
主要发现
- 2年内≥2次CRS的ICD-9编码(471.x或473.x)索赔的病例定义灵敏度为77%、特异度为79%。
- 应用该CRS病例定义于索赔数据库产生51,000例CRS队列,其特征与已发表的人口学特征及合并哮喘、过敏性鼻炎和抑郁的比例一致。
关键数值与推荐
- CRS病例定义:2年内≥2次CRS的ICD-9编码(471.x或473.x)索赔,灵敏度77%、特异度79%。
局限性
- 未来研究需要从不同卫生系统视角验证该行政病例定义,并使用来自多个提供者的更大规模回顾性病历审查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pharmacoepidemiological research using administrative databases has become increasingly popular for chronic rhinosinusitis (CRS); however, without a validated case definition the cohort evaluated may be inaccurate resulting in biased and incorrect outcomes. The objective of this study was to develop and validate a generalizable administrative database case definition for CRS using International Classification of Diseases, 9th edition (ICD-9)-coded claims. METHODS: A random sample of 100 patients with a guideline-based diagnosis of CRS and 100 control patients were selected and then linked to a Canadian physician claims database from March 31, 2010, to March 31, 2015. The proportion of CRS ICD-9-coded claims (473.x and 471.x) for each of these 200 patients were reviewed and the validity of 7 different ICD-9-based coding algorithms was evaluated. RESULTS: The CRS case definition of ≥2 claims with a CRS ICD-9 code (471.x or 473.x) within 2 years of the reference case provides a balanced validity with a sensitivity of 77% and specificity of 79%. Applying this CRS case definition to the claims database produced a CRS cohort of 51,000 patients with characteristics that were consistent with published demographics and rates of comorbid asthma, allergic rhinitis, and depression. CONCLUSION: This study has validated several coding algorithms; based on the results a case definition of ≥2 physician claims of CRS (ICD-9 of 471.x or 473.x) within 2 years provides an optimal level of validity. Future studies will need to validate this administrative case definition from different health system perspectives and using larger retrospective chart reviews from multiple providers.
引用
- Rudmik L, Xu Y, Kukec E, et al. A validated case definition for chronic rhinosinusitis in administrative data: a Canadian perspective. Int Forum Allergy Rhinol. 2016. PMID: 27228224. doi:10.1002/alr.21801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。